Perspective Therapeutics (CATX) Common Equity (2011 - 2026)
Perspective Therapeutics (CATX) posted Common Equity of $347.4 million for Q1 2026, up 67.82% sequentially from $207.0 million in Q4 2025, and up 22.06% YoY from $284.6 million in Q1 2025.
Perspective Therapeutics (CATX) Common Equity (2011 - 2026) Analysis & Trends
Perspective Therapeutics has reported Common Equity for 16 years, with the latest figure at $347.4 million in Q1 2026.
- Quarterly Common Equity rose 22.06% year-over-year to $347.4 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $347.4 million (up 22.06% YoY) and the FY2025 annual result came in at $207.0 million, down 28.77% from the prior year.
- Common Equity grew to $347.4 million in Q1 2026 per CATX's latest filing, from $207.0 million in the prior quarter.
- Over five years, Common Equity peaked at $347.4 million in Q1 2026 and troughed at $54.6 million in Q4 2022.
- A 5-year average of $186.7 million and a median of $207.0 million in 2025 frame the typical range for Common Equity.
- The sharpest annual moves came in 2024 and 2025: Common Equity jumped 286.63% in 2024, then decreased 28.77% in 2025.
- Over 5 years, Common Equity stood at $54.6 million in 2022, then jumped by 37.58% to $75.2 million in 2023, then surged by 286.63% to $290.7 million in 2024, then fell by 28.77% to $207.0 million in 2025, then surged by 67.82% to $347.4 million in 2026.
- According to Business Quant data, Common Equity over the past three periods registered $347.4 million, $207.0 million, and $242.2 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Common Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.12 Bn | 193.52 Bn | 7.27 Bn | 51.76 Bn |
| 2 | Stryker | 128.79 Bn | 125.32 Bn | 4.50 Bn | 23.99 Bn |
| 3 | Medtronic | 119.30 Bn | 110.08 Bn | 6.41 Bn | 50.07 Bn |
| 4 | Boston Scientific | 73.50 Bn | 72.96 Bn | 3.85 Bn | 25.17 Bn |
| 5 | Edwards Lifesciences | 52.11 Bn | 47.86 Bn | 1.35 Bn | 10.72 Bn |
| 6 | Dexcom | 34.62 Bn | 32.67 Bn | 830.00 Mn | 2.62 Bn |
| 7 | GE HealthCare Technologies | 34.05 Bn | 31.94 Bn | 2.18 Bn | 10.99 Bn |
| 8 | Koninklijke Philips | 26.42 Bn | 23.10 Bn | 4.55 Bn | 13.31 Bn |
| 9 | Steris | 23.15 Bn | 22.67 Bn | 684.20 Mn | 7.22 Bn |
| 10 | Perspective Therapeutics | 387.89 Mn | 387.89 Mn | - | 323.86 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 323.86 Mn |
| Mar 31, 2026 | 347.44 Mn |
| Dec 31, 2025 | 207.03 Mn |
| Sep 30, 2025 | 242.22 Mn |
| Jun 30, 2025 | 265.69 Mn |
| Mar 31, 2025 | 284.65 Mn |
| Dec 31, 2024 | 290.67 Mn |
| Sep 30, 2024 | 328.47 Mn |
| Jun 30, 2024 | 341.00 Mn |
| Mar 31, 2024 | 229.89 Mn |
| Dec 31, 2023 | 75.18 Mn |
| Sep 30, 2023 | 98.77 Mn |
| Jun 30, 2023 | 108.65 Mn |
| Mar 31, 2023 | 118.03 Mn |
| Dec 31, 2022 | 54.64 Mn |
| Sep 30, 2022 | 57.70 Mn |
| Jun 30, 2022 | 61.28 Mn |
| Mar 31, 2022 | 63.20 Mn |
| Dec 31, 2021 | 64.39 Mn |
| Sep 30, 2021 | 65.76 Mn |